Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/09/2003US6659985 Method to use transdermal administration of androgens to the adnexa of the eye
12/09/2003US6659282 Antiinflammatory lipoxing derivatives
12/09/2003US6659107 Sensitization of cells with porphyrins, then exposing to radiation and grafting; photodynamic therapy
12/09/2003CA2410867C Stable gabapentin containing more than 2o ppm of chlorine ion
12/09/2003CA2376833C Oxidatively stable, long-chain ethyl ester emollients
12/09/2003CA2306103C Novel once-a-day controlled release sulfonylurea formulation
12/09/2003CA2301649C Burn treatment composition
12/09/2003CA2272880C Composition and method for reducing stinging in skin
12/09/2003CA2266318C Flavonol containing food supplements
12/09/2003CA2264985C 6,8-dimercarptooctanoic acid derivatives substituted in 6-s and/or 8-s by the radical (3-methylthiopropanoyl) and pharmaceutical compositions used to treat cancerous tumors
12/09/2003CA2261772C Process and apparatus for the production of bi-212 and a use thereof
12/09/2003CA2227298C Paroxetine controlled release compositions
12/09/2003CA2140247C Novel vitamin d analogues
12/09/2003CA2123697C Novel substituted salicylic acids
12/09/2003CA2106967C Thiazolidinedione derivatives, production and use thereof
12/09/2003CA2105002C The production of pellets composed of an ephedrine derivative
12/09/2003CA2104776C Thalidomide derivatives, method of manufacture and use thereof in medicaments
12/09/2003CA2103707C Treatment of non-small cell lung carcinoma
12/09/2003CA2094457C Monoquaternary 2,16-bispiperidinylandrostane derivatives
12/09/2003CA2086811C 4,13-dioxabicyclo [8.2.1] tridecenone compounds process and intermediates for their preparation and pharmaceutical compositions containing them
12/09/2003CA2083305C Pharmaceutical compositions for oral use and method of preparing them
12/09/2003CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
12/09/2003CA2069202C The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
12/09/2003CA2053716C Pesticidal 1-arylimidazoles
12/09/2003CA2022425C 1,3,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
12/06/2003CA2431338A1 Method for preventing decrease of breast milk amount in mammals
12/06/2003CA2389634A1 Fused tri-heterocyclic compounds
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100099A1 Parallel stranded duplexes of deoxyribonucleic acid and methods of use
12/04/2003WO2003100091A1 Means and methods for improved treatment using 'setrones'
12/04/2003WO2003100064A1 Novel ubiquitin ligase
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003100036A2 Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
12/04/2003WO2003100023A2 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
12/04/2003WO2003100009A2 Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof
12/04/2003WO2003100005A2 Universal chimera bank
12/04/2003WO2003099992A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003WO2003099874A1 Extraction of unmilled psyllium
12/04/2003WO2003099851A2 Methods and compositions for inhibiting hiv replication
12/04/2003WO2003099844A2 Protease inhibitors
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099835A1 Multivalent polymers with chain-terminating binding groups
12/04/2003WO2003099830A2 Cardiolipin compositions, methods of preparation and use
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099824A1 R-enantiomers of pyranoindole derivatives against hepatitis c
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099821A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099817A1 8-fluorimidazo`1,2-a!pyridine derivatives as ligands for gaba receptors
12/04/2003WO2003099816A1 Imidazo-pyridine derivatives as ligands for gaba receptors
12/04/2003WO2003099814A1 Calcium receptor modulating agents
12/04/2003WO2003099813A1 Novel physiolgically active substances
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099809A1 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY α4 INTEGRINS
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099807A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099795A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors
12/04/2003WO2003099792A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
12/04/2003WO2003099787A1 Novel piperidine compound
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099783A2 Tropane compounds
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099775A1 Sulfone liver x-receptor modulators
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099767A1 Amide derivatives as inhibitors of the enzymatic activity of renin
12/04/2003WO2003099764A1 ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
12/04/2003WO2003099763A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
12/04/2003WO2003099762A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003WO2003099759A1 Preparation and application of transhintotalphenolic acid
12/04/2003WO2003099362A1 Aerosol drug inhibition of lung metastases
12/04/2003WO2003099339A1 Decoy composition for treating and preventing inflammatory disease
12/04/2003WO2003099337A2 Inclusion complexes of rosiglitazone
12/04/2003WO2003099336A1 Formulation for parenteral administration of sodium channel blockers
12/04/2003WO2003099335A1 Potassium alginate as pharmaceutical excipient and compositions thereof
12/04/2003WO2003099334A1 Topically applicable pharmaceutical preparation
12/04/2003WO2003099333A1 Methods of controlling fertility, cancers and reproductive tract diseases
12/04/2003WO2003099332A1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof
12/04/2003WO2003099331A1 Insulin resistance improving agents
12/04/2003WO2003099330A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003WO2003099329A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003WO2003099327A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
12/04/2003WO2003099323A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
12/04/2003WO2003099321A1 Methods for preventing, treating or delaying cardiac toxicity using neuregulin
12/04/2003WO2003099320A1 Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
12/04/2003WO2003099316A1 Heterocyclicsulfonamide hepatitis c virus inhibitors
12/04/2003WO2003099310A1 Antifungal effects of morinda citrifolia
12/04/2003WO2003099309A1 Active fraction having anti-cancer and anti-metastasis isolated from acanthopanax species and fruits
12/04/2003WO2003099308A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng
12/04/2003WO2003099304A1 Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition
12/04/2003WO2003099301A1 Formulation containing tetrodotoxin for abstinence and analgecize which is administered through respiratory tract
12/04/2003WO2003099300A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003WO2003099299A1 Agents and methods for the treatment of disorders associated with motor neuron degeneration
1 ... 5251 5252 5253 5254 5255 5256 5257 5258 5259 5260 5261 5262 5263 5264 5265 5266 5267 5268 5269 5270 5271 ... 7860